Literature DB >> 2555178

HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes.

P Hawley-Nelson1, K H Vousden, N L Hubbert, D R Lowy, J T Schiller.   

Abstract

The human papillomavirus types (HPVs) most often associated with cancer of the cervix, such as HPV16, have been reported previously to immortalize normal human foreskin keratinocytes in vitro, while the types that are primarily associated with benign cervical lesions failed to do so. In this study we have determined the HPV16 genes that are responsible for the immortalizing activity of the viral genome. Transfection with a plasmid in which E6 and E7 were the only intact open reading frames (ORFs) induced an indefinite life-span in the keratinocytes with an efficiency similar to that of the entire early region of the viral DNA. Mutants in the E6E7 clone with inactivating lesions in E6 or E7 failed to induce immortalization. When transfected alone, E7 could induce hyperproliferation, but these cells eventually senesced. By itself, E6 exhibited no activity, Co-transfection of a plasmid with an intact E6 ORF and a second plasmid with an intact E7 ORF generated keratinocyte lines with indefinite growth potential. The E6 and E7 proteins were detected in the lines induced by the E6E7 DNA and by co-transfection of the E6 and E7 plasmids. Therefore, we conclude that HPV16 E6 and E7 cooperative to immortalize human keratinocytes in vitro. Changes in cellular gene expression are probably also required for immortalization since all of the keratinocyte lines examined were aneuploid. Serum and calcium resistant sublines were isolated from the E6E7 induced lines, indicating that other HPV genes do not play an obligatory role in the generation of resistance to differentiation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555178      PMCID: PMC402081          DOI: 10.1002/j.1460-2075.1989.tb08570.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  46 in total

1.  Inducible and constitutive enhancer domains in the noncoding region of human papillomavirus type 18.

Authors:  D Gius; S Grossman; M A Bedell; L A Laimins
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  Functional dissociation of transforming genes of human papillomavirus type 16.

Authors:  M Yutsudo; Y Okamoto; A Hakura
Journal:  Virology       Date:  1988-10       Impact factor: 3.616

3.  Human papillomavirus type 16 cooperates with activated ras and fos oncogenes in the hormone-dependent transformation of primary mouse cells.

Authors:  T Crook; A Storey; N Almond; K Osborn; L Crawford
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

4.  Characterization of normal human exocervical epithelial cells immortalized in vitro by papillomavirus types 16 and 18 DNA.

Authors:  C D Woodworth; P E Bowden; J Doniger; L Pirisi; W Barnes; W D Lancaster; J A DiPaolo
Journal:  Cancer Res       Date:  1988-08-15       Impact factor: 12.701

5.  Characterization of primary human keratinocytes transformed by human papillomavirus type 18.

Authors:  P Kaur; J K McDougall
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

6.  Continuous cell lines with altered growth and differentiation properties originate after transfection of human keratinocytes with human papillomavirus type 16 DNA.

Authors:  L Pirisi; K E Creek; J Doniger; J A DiPaolo
Journal:  Carcinogenesis       Date:  1988-09       Impact factor: 4.944

7.  Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA.

Authors:  M Dürst; R T Dzarlieva-Petrusevska; P Boukamp; N E Fusenig; L Gissmann
Journal:  Oncogene       Date:  1987       Impact factor: 9.867

8.  Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells.

Authors:  M von Knebel Doeberitz; T Oltersdorf; E Schwarz; L Gissmann
Journal:  Cancer Res       Date:  1988-07-01       Impact factor: 12.701

9.  Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma.

Authors:  R Schlegel; W C Phelps; Y L Zhang; M Barbosa
Journal:  EMBO J       Date:  1988-10       Impact factor: 11.598

10.  Comparison of the in vitro transforming activities of human papillomavirus types.

Authors:  A Storey; D Pim; A Murray; K Osborn; L Banks; L Crawford
Journal:  EMBO J       Date:  1988-06       Impact factor: 11.598

View more
  312 in total

Review 1.  Cell-mediated immune response to human papillomavirus infection.

Authors:  M Scott; M Nakagawa; A B Moscicki
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

2.  PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum.

Authors:  I C Le Poole; R E Boissy; R Sarangarajan; J Chen; J J Forristal; P Sheth; W Westerhof; G Babcock; P K Das; C B Saelinger
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-05       Impact factor: 2.416

3.  Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.

Authors:  A M Helt; D A Galloway
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites.

Authors:  S T Oh; S Kyo; L A Laimins
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

5.  Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3.

Authors:  B Mannhardt; S A Weinzimer; M Wagner; M Fiedler; P Cohen; P Jansen-Dürr; W Zwerschke
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

6.  The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth.

Authors:  A Brehm; S J Nielsen; E A Miska; D J McCance; J L Reid; A J Bannister; T Kouzarides
Journal:  EMBO J       Date:  1999-05-04       Impact factor: 11.598

7.  E6-associated protein is required for human papillomavirus type 16 E6 to cause cervical cancer in mice.

Authors:  Anny Shai; Henry C Pitot; Paul F Lambert
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

Review 8.  [HPV-associated squamous cell carcinogenesis].

Authors:  G Assmann; K Sotlar
Journal:  Pathologe       Date:  2011-09       Impact factor: 1.011

9.  Sequence variation of human papillomavirus type 16 E7 in preinvasive and invasive cervical neoplasias.

Authors:  Y Fujinaga; K Okazawa; A Nishikawa; Y Yamakawa; M Fukushima; I Kato; K Fujinaga
Journal:  Virus Genes       Date:  1994-09       Impact factor: 2.332

10.  Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis.

Authors:  S Jeon; P F Lambert
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.